NCT00839930View on ClinicalTrials.gov

Cilostazol 50 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Healthy
Interventions
DRUG

Cilostazol 50 mg Tablets

1 x 50 mg, single-dose fasting

DRUG

Pletal®

1 x 50 mg, single-dose tablet

Trial Locations (2)

56721

PRACS Institute Ltd., East Grand Forks

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00839930 - Cilostazol 50 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter